ProQR makes progress with potential treatment for LCA
Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss.
Search results
Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss.
An American living with Leber congenital amaurosis 10 (LCA10) has become the first clinical trial participant in the world to receive a CRISPR gene editing treatment in vivo (inside the body).
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
The latest podcast from Retina UK.
Retina UK is a charity supporting people affected by inherited sight loss and investing in medical research to help make their challenges a thing of the past.
Retina UK has a number of online support resources which we offer via social media.
Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.
Celebrate the life of your loved one, by donating in their memory and help us fund more research and support, now.
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.